Document Detail


Correlation between the aPTT and clinical events in acute coronary syndromes treated with unfractionated heparin.
MedLine Citation:
PMID:  17425158     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: The primary objective of this study is to analyse relationship between activated partial thromboplastin time (aPTT) and clinical events in patients with unstable coronary artery disease. BACKGROUND: Unfractionated heparin (UFH) is considered as a standard therapy in the management of unstable coronary artery disease. His efficacy is concerned to low rate of adverse events, but it shows lack of correlation between aPTT and clinical outcomes. METHODS: Thirty patients with acute coronary syndromes were randomised to receive weight-adjusted unfractionated heparin (Heparin-"Biochemie" 25.000 IU/5 ml), according to Rashke nomogram. Six hours after the initial bolus dose, the aPTT was measured and the heparin infusion was adjusted. Relationship between the aPTT and the day of onset of recurrent angina (RA), myocardial infarction (MI), heart failure (HF), death, and target vascular revasularization (TVR) during six months follow-up was evaluated. RESULTS: At 6 h, 40 % of patients achieved the target level of aPTT (60-85 sec). Also, 40 % patients were below the target range, 41.6 % had aPTT less than 30 sec and 20 % were above the target range. We noted significant difference between heparin dosing and aPTT (p=0.0000). But we did not find significant difference between aPTT and outcomes as RA and MI (p=1.0, p=0.42). Pearson Product Moment Correlation shows negative correlations between aPTT and the day of onset of RA (r=-0.05) and TVR (r=-0.23), and pozitive correlations for MI (r=0.35) and death (r=0.87). CONCLUSION: The level of aPTT shows discordance with the onset of clinical events and is a weak predictor of outcomes (Tab. 2, Fig. 7, Ref 5).
Authors:
S Mitrovska; S Jovanova
Related Documents :
16432978 - Acute limb ischemia secondary to heparin-induced thrombocytopenia after cardiac surgery.
18586338 - Long-term cost-effectiveness of clopidogrel in stemi patients.
22845488 - Atrial bigeminy results in decreased left ventricular function: an insight into the mec...
16892428 - Direct thrombin inhibition appears to be a safe and effective anticoagulant for percuta...
18810718 - Timing of life-threatening arrhythmias detected by implantable cardioverter-defibrillat...
17599858 - Acute myocardial infarction attributable to adrenergic crises in a patient with pheochr...
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Bratislavské lekárske listy     Volume:  107     ISSN:  0006-9248     ISO Abbreviation:  Bratisl Lek Listy     Publication Date:  2006  
Date Detail:
Created Date:  2007-04-11     Completed Date:  2007-06-07     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0065324     Medline TA:  Bratisl Lek Listy     Country:  Slovakia    
Other Details:
Languages:  eng     Pagination:  422-5     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Military Hospital, Skopje, Macedonia. mitrovska2000@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Angina, Unstable / blood,  drug therapy*
Anticoagulants / therapeutic use*
Heparin / therapeutic use*
Humans
Myocardial Infarction / blood,  drug therapy*
Partial Thromboplastin Time*
Recurrence
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anticoagulants; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Systematic isolation and characterization of cDNAs encoding AAA proteins from human brain.
Next Document:  Valsalva leak point pressure predicts outcome after transobturator suburethral tape implantation--fa...